Cargando…

Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes

Two novel phosphine ligands, Ph(2)PCH(2)N(CH(2)CH(3))(3) (1) and Ph(2)PCH(2)N(CH(2)CH(2)CH(2)CH(3))(2) (2), and six new metal (Cu(I), Ir(III) and Ru(II)) complexes with those ligands: iridium(III) complexes: Ir(η5-Cp*)Cl(2)(1) (1a), Ir(η5-Cp*)Cl(2)(2) (2a) (Cp*: Pentamethylcyclopentadienyl); rutheni...

Descripción completa

Detalles Bibliográficos
Autores principales: Komarnicka, Urszula K., Niorettini, Alessandro, Kozieł, Sandra, Pucelik, Barbara, Barzowska, Agata, Wojtala, Daria, Ziółkowska, Aleksandra, Lesiów, Monika, Kyzioł, Agnieszka, Caramori, Stefano, Porchia, Marina, Bieńko, Alina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876511/
https://www.ncbi.nlm.nih.gov/pubmed/35215281
http://dx.doi.org/10.3390/ph15020169
_version_ 1784658192358178816
author Komarnicka, Urszula K.
Niorettini, Alessandro
Kozieł, Sandra
Pucelik, Barbara
Barzowska, Agata
Wojtala, Daria
Ziółkowska, Aleksandra
Lesiów, Monika
Kyzioł, Agnieszka
Caramori, Stefano
Porchia, Marina
Bieńko, Alina
author_facet Komarnicka, Urszula K.
Niorettini, Alessandro
Kozieł, Sandra
Pucelik, Barbara
Barzowska, Agata
Wojtala, Daria
Ziółkowska, Aleksandra
Lesiów, Monika
Kyzioł, Agnieszka
Caramori, Stefano
Porchia, Marina
Bieńko, Alina
author_sort Komarnicka, Urszula K.
collection PubMed
description Two novel phosphine ligands, Ph(2)PCH(2)N(CH(2)CH(3))(3) (1) and Ph(2)PCH(2)N(CH(2)CH(2)CH(2)CH(3))(2) (2), and six new metal (Cu(I), Ir(III) and Ru(II)) complexes with those ligands: iridium(III) complexes: Ir(η5-Cp*)Cl(2)(1) (1a), Ir(η5-Cp*)Cl(2)(2) (2a) (Cp*: Pentamethylcyclopentadienyl); ruthenium(II) complexes: Ru(η6-p-cymene)Cl(2)(1) (1b), Ru(η6-p-cymene)Cl(2)(2) (2b) and copper(I) complexes: [Cu(CH(3)CN)(2)(1)BF(4)] (1c), [Cu(CH(3)CN)(2)(2)BF(4)] (2c) were synthesized and characterized using elemental analysis, NMR spectroscopy, and ESI-MS spectrometry. Copper(I) complexes turned out to be highly unstable in the presence of atmospheric oxygen in contrast to ruthenium(II) and iridium(III) complexes. The studied Ru(II) and Ir(III) complexes exhibited promising cytotoxicity towards cancer cells in vitro with IC(50) values significantly lower than that of the reference drug—cisplatin. Confocal microscopy analysis showed that Ru(II) and Ir(III) complexes effectively accumulate inside A549 cells with localization in cytoplasm and nuclei. A precise cytometric analysis provided clear evidence for the predominance of apoptosis in induced cell death. Furthermore, the complexes presumably induce the changes in the cell cycle leading to G2/M phase arrest in a dose-dependent manner. Gel electrophoresis experiments revealed that Ru(II) and Ir(III) inorganic compounds showed their unusual low genotoxicity towards plasmid DNA. Additionally, metal complexes were able to generate reactive oxygen species as a result of redox processes, proved by gel electrophoresis and cyclic voltamperometry. In vitro cytotoxicity assays were also carried out within multicellular tumor spheroids and efficient anticancer action on these 3D assemblies was demonstrated. It was proven that the hydrocarbon chain elongation of the phosphine ligand coordinated to the metal ions does not influence the cytotoxic effect of resulting complexes in contrast to metal ions type.
format Online
Article
Text
id pubmed-8876511
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88765112022-02-26 Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes Komarnicka, Urszula K. Niorettini, Alessandro Kozieł, Sandra Pucelik, Barbara Barzowska, Agata Wojtala, Daria Ziółkowska, Aleksandra Lesiów, Monika Kyzioł, Agnieszka Caramori, Stefano Porchia, Marina Bieńko, Alina Pharmaceuticals (Basel) Article Two novel phosphine ligands, Ph(2)PCH(2)N(CH(2)CH(3))(3) (1) and Ph(2)PCH(2)N(CH(2)CH(2)CH(2)CH(3))(2) (2), and six new metal (Cu(I), Ir(III) and Ru(II)) complexes with those ligands: iridium(III) complexes: Ir(η5-Cp*)Cl(2)(1) (1a), Ir(η5-Cp*)Cl(2)(2) (2a) (Cp*: Pentamethylcyclopentadienyl); ruthenium(II) complexes: Ru(η6-p-cymene)Cl(2)(1) (1b), Ru(η6-p-cymene)Cl(2)(2) (2b) and copper(I) complexes: [Cu(CH(3)CN)(2)(1)BF(4)] (1c), [Cu(CH(3)CN)(2)(2)BF(4)] (2c) were synthesized and characterized using elemental analysis, NMR spectroscopy, and ESI-MS spectrometry. Copper(I) complexes turned out to be highly unstable in the presence of atmospheric oxygen in contrast to ruthenium(II) and iridium(III) complexes. The studied Ru(II) and Ir(III) complexes exhibited promising cytotoxicity towards cancer cells in vitro with IC(50) values significantly lower than that of the reference drug—cisplatin. Confocal microscopy analysis showed that Ru(II) and Ir(III) complexes effectively accumulate inside A549 cells with localization in cytoplasm and nuclei. A precise cytometric analysis provided clear evidence for the predominance of apoptosis in induced cell death. Furthermore, the complexes presumably induce the changes in the cell cycle leading to G2/M phase arrest in a dose-dependent manner. Gel electrophoresis experiments revealed that Ru(II) and Ir(III) inorganic compounds showed their unusual low genotoxicity towards plasmid DNA. Additionally, metal complexes were able to generate reactive oxygen species as a result of redox processes, proved by gel electrophoresis and cyclic voltamperometry. In vitro cytotoxicity assays were also carried out within multicellular tumor spheroids and efficient anticancer action on these 3D assemblies was demonstrated. It was proven that the hydrocarbon chain elongation of the phosphine ligand coordinated to the metal ions does not influence the cytotoxic effect of resulting complexes in contrast to metal ions type. MDPI 2022-01-29 /pmc/articles/PMC8876511/ /pubmed/35215281 http://dx.doi.org/10.3390/ph15020169 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Komarnicka, Urszula K.
Niorettini, Alessandro
Kozieł, Sandra
Pucelik, Barbara
Barzowska, Agata
Wojtala, Daria
Ziółkowska, Aleksandra
Lesiów, Monika
Kyzioł, Agnieszka
Caramori, Stefano
Porchia, Marina
Bieńko, Alina
Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes
title Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes
title_full Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes
title_fullStr Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes
title_full_unstemmed Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes
title_short Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes
title_sort two out of three musketeers fight against cancer: synthesis, physicochemical, and biological properties of phosphino cu(i), ru(ii), ir(iii) complexes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876511/
https://www.ncbi.nlm.nih.gov/pubmed/35215281
http://dx.doi.org/10.3390/ph15020169
work_keys_str_mv AT komarnickaurszulak twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT niorettinialessandro twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT koziełsandra twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT pucelikbarbara twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT barzowskaagata twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT wojtaladaria twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT ziołkowskaaleksandra twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT lesiowmonika twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT kyziołagnieszka twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT caramoristefano twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT porchiamarina twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes
AT bienkoalina twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes